Pay in 4 interest-free payments of $6.31 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Triple Agonists (GLP-1/GIP/Glucagon) Drug-Drug Interaction Table At a glance Prototype drug / retatrutide (LY3437943) Mechanism / simultaneous GLP-1R, GIPR, and glucagon receptor agonism Phase 2 weight loss (48 wk) / 24.2% mean body weight reduction vs 2.1% placebo Primary metabolic targets / obesity, MASLD/MASH, T2D, dyslipidemia Gastric emptying effect / marked slowing, peak drug interaction risk 1 to 4 h post-dose Oral drug most affected / warfarin, oral contraceptives, levothyroxine, cyclosporine Hypoglycemia risk / low monotherapy
Telehealth platforms Felix Health and Hims Canada also dispense it
Tesamorelin delivers a targeted, measurable reduction in deep belly fat that other peptides do not consistently match
Novo spokeswoman Ambre James-Brown described Hims mass compounding as illegal
It also lowers blood sugar to prevent harmful effects of high blood sugar
US$ 22.73
US$ 21.20
US$ 26.03
US$ 24.84
